Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
Overview
Affiliations
It has been reported that the progression of osteosarcoma was closely associated with the aberrant activation of canonical Wnt signaling. Wnt inhibitory factor-1 (WIF-1) is a secreted Wnt inhibitor whose role in human osteosarcoma remains unknown. In this study, WIF-1 expression in NHOst and osteosarcoma cell lines was determined by real-time reverse transcription-PCR, methylation-specific PCR, and Western blotting analysis. In addition, tissue array from patient samples was examined for WIF-1 expression by immunohistochemistry. Compared with normal human osteoblasts, WIF-1 mRNA and protein levels were significantly downregulated in several osteosarcoma cell lines. The downregulation of WIF-1 mRNA expression is associated with its promoter hypermethylation in these tested cell lines. Importantly, WIF-1 expression was also downregulated in 76% of examined osteosarcoma cases. These results suggest that the downregulation of WIF-1 expression plays a role in osteosarcoma progression. To further study the potential tumor suppressor function of WIF-1 in osteosarcoma, we established stable 143B cell lines overexpressing WIF-1. WIF-1 overexpression significantly decreased tumor growth rate in nude mice as examined by the s.c. injection of 143B cells stably transfected with WIF-1 and vector control. WIF-1 overexpression also markedly reduced the number of lung metastasis in vivo in an orthotopic mouse model of osteosarcoma. Together, these data suggest that WIF-1 exerts potent antiosteosarcoma effect in vivo in mouse models. Therefore, the reexpression of WIF-1 in WIF-1-deficient osteosarcoma represents a potential novel treatment and preventive strategy.
Eslaminejad T, Nematollahi-Mahani S, Lotfian Sargazi M, Ansari M, Mirzaie V Diagn Pathol. 2024; 19(1):35.
PMID: 38365810 PMC: 10870642. DOI: 10.1186/s13000-024-01468-3.
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
Fattahi M, Rezaee D, Fakhari F, Najafi S, Aghaei-Zarch S, Beyranvand P Cell Death Discov. 2023; 9(1):423.
PMID: 38001121 PMC: 10673883. DOI: 10.1038/s41420-023-01718-1.
Qin K, Yu M, Fan J, Wang H, Zhao P, Zhao G Genes Dis. 2023; 11(1):103-134.
PMID: 37588235 PMC: 10425814. DOI: 10.1016/j.gendis.2023.01.030.
Martins-Neves S, Sampaio-Ribeiro G, Gomes C Int J Mol Sci. 2023; 24(9).
PMID: 37176108 PMC: 10179672. DOI: 10.3390/ijms24098401.
Son J, Cha H, Lee S, Bae Y, Ryou C, Lee S Mol Biol Rep. 2023; 50(5):4029-4038.
PMID: 36848005 DOI: 10.1007/s11033-023-08333-4.